ABVC - ABVC BIOPHARMA, INC.
1
-0.060 -6.000%
Share volume: 75,271
Last Updated: 03-27-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.18%
PREVIOUS CLOSE
CHG
CHG%
$1.06
-0.06
-0.06%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-17-2024 | 08-14-2024 | 11-14-2024 | 04-30-2025 | 08-13-2025 | 10-31-2025 | 03-03-2026 | |
| Cash flow financing | 676.166 K | 868.540 K | -145.393 K | 428.756 K | 1.927 M | 1.132 M | 1.150 M | |
| Other financing cash flows | 0.000 | 0.000 | 164.772 K | 411.667 K | 0.000 | 579.699 K | 390.000 K | |
| Cash flow | 203.005 K | 0.000 | 0.000 | -111.077 K | 367.374 K | -274.219 K | 460.828 K | |
| Net income | -3.981 M | -1.273 M | -134.272 K | -944.190 K | -2.333 M | -1.288 M | -3.812 M | |
| Depreciation | 1.286 K | 13.305 K | 7.014 K | 7.021 K | 6.697 K | 5.821 K | 5.791 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 11.460 K | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | 0.000 | -665.779 K | -1.273 M | 730.346 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 202.653 K | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | -57.778 K | 83.767 K | 27.104 K | -104.247 K | 316.758 K | -230.433 K | 460.828 K |